A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs
Identifieur interne : 00E480 ( Main/Curation ); précédent : 00E479; suivant : 00E481A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs
Auteurs : N. B. Piller [Australie] ; R. Gwyn Morgan [Australie] ; J. R. Casley-Smith [Australie]Source :
- British Journal of Plastic Surgery [ 0007-1226 ] ; 1988.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Attribution aléatoire, Bras, Complications postopératoires (traitement médicamenteux), Essais cliniques comme sujet, Femelle, Humains, Jambe, Lymphoedème (physiopathologie), Lymphoedème (traitement médicamenteux), Mastectomie, Mâle, Méthode en double aveugle, O-(bêta-Hydroxyéthyl)rutosides (administration et posologie), O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés), O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique), Rutoside (analogues et dérivés), Température cutanée ().
- MESH :
- administration et posologie : O-(bêta-Hydroxyéthyl)rutosides.
- analogues et dérivés : O-(bêta-Hydroxyéthyl)rutosides, Rutoside.
- physiopathologie : Lymphoedème.
- traitement médicamenteux : Complications postopératoires, Lymphoedème.
- usage thérapeutique : O-(bêta-Hydroxyéthyl)rutosides.
- Adulte d'âge moyen, Attribution aléatoire, Bras, Essais cliniques comme sujet, Femelle, Humains, Jambe, Mastectomie, Mâle, Méthode en double aveugle, Température cutanée.
English descriptors
- KwdEn :
- Arm, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Hydroxyethylrutoside (administration & dosage), Hydroxyethylrutoside (analogs & derivatives), Hydroxyethylrutoside (therapeutic use), Leg, Lymphedema (drug therapy), Lymphedema (physiopathology), Male, Mastectomy, Middle Aged, Postoperative Complications (drug therapy), Random Allocation, Rutin (analogs & derivatives), Skin Temperature (drug effects).
- MESH :
- chemical , administration & dosage : Hydroxyethylrutoside.
- chemical , analogs & derivatives : Hydroxyethylrutoside, Rutin.
- chemical , therapeutic use : Hydroxyethylrutoside.
- drug effects : Skin Temperature.
- drug therapy : Lymphedema, Postoperative Complications.
- physiopathology : Lymphedema.
- Arm, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Leg, Male, Mastectomy, Middle Aged, Random Allocation.
Abstract
Abstract: A randomised, double-blind, cross-over trial was performed on 26 patients with post-mastectomy lymphoedema of the arm, and 14 with lymphoedema of the leg. For 6 months, patients took O-(β-hydroxyethyl)-rutosides (oxerutin; “Paroven®”, “Venoruton®”, Zyma) in doses of 3 g/day, or the placebos; then they took the reverse. Measurements (volume, circumferences, tonometry and skin temperature) were made monthly. The active drug reduced the volumes of the limbs (p<0.05 to 0.01) and their circumferences (p<0.05 to 0.001). It increased the softness of the limbs, as shown by the increases in the tonometry values (p<0.01 to 0.001). There was a lowering of the elevated skin temperatures (p<0.05 to 0.001). Patients reported increased comfort and freedom of movement, a lessening of their bursting pains, heaviness and tension (p<0.05 to 0.01), and an increased mobility of their limbs (p<0.0001). Most patients (70%) preferred the active drug (p<0.0001). An increase in general well-being was reported by 97% of patients when taking the active drug compared with 4% for the placebo (p<0.0001).
Url:
DOI: 10.1016/0007-1226(88)90139-7
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :007132
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :007132
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :005A41
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :00F170
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :006262
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :006262
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :006262
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :009669
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :009669
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :009669
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :00F004
Links to Exploration step
ISTEX:F1AB2C3158F33CBC34B96C103F24B762D9D9564CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name></author><author><name sortKey="Morgan, R Gwyn" sort="Morgan, R Gwyn" uniqKey="Morgan R" first="R. Gwyn" last="Morgan">R. Gwyn Morgan</name></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F1AB2C3158F33CBC34B96C103F24B762D9D9564C</idno><date when="1988" year="1988">1988</date><idno type="doi">10.1016/0007-1226(88)90139-7</idno><idno type="url">https://api.istex.fr/document/F1AB2C3158F33CBC34B96C103F24B762D9D9564C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007132</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007132</idno><idno type="wicri:Area/Istex/Curation">007132</idno><idno type="wicri:Area/Istex/Checkpoint">005A41</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">005A41</idno><idno type="wicri:doubleKey">0007-1226:1988:Piller N:a:double:blind</idno><idno type="wicri:Area/Main/Merge">00F170</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:3278764</idno><idno type="wicri:Area/PubMed/Corpus">006262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006262</idno><idno type="wicri:Area/PubMed/Curation">006262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006262</idno><idno type="wicri:Area/PubMed/Checkpoint">006262</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006262</idno><idno type="wicri:Area/Ncbi/Merge">009669</idno><idno type="wicri:Area/Ncbi/Curation">009669</idno><idno type="wicri:Area/Ncbi/Checkpoint">009669</idno><idno type="wicri:doubleKey">0007-1226:1988:Piller N:a:double:blind</idno><idno type="wicri:Area/Main/Merge">00F004</idno><idno type="wicri:Area/Main/Curation">00E480</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences and Education, Sturt College Advanced Education, Bedford Park</wicri:regionArea><wicri:noRegion>Bedford Park</wicri:noRegion></affiliation></author><author><name sortKey="Morgan, R Gwyn" sort="Morgan, R Gwyn" uniqKey="Morgan R" first="R. Gwyn" last="Morgan">R. Gwyn Morgan</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Surgery, The Flinder's Medical Centre, Bedford Park</wicri:regionArea><wicri:noRegion>Bedford Park</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name><affiliation></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>The Henry Thomas Laboratory (Microcirculation Research), University of Adelaide, Box 498 GPO, Adelaide, SA 5001</wicri:regionArea><wicri:noRegion>SA 5001</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">British Journal of Plastic Surgery</title><title level="j" type="abbrev">YBJPS</title><idno type="ISSN">0007-1226</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1988">1988</date><biblScope unit="volume">41</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="20">20</biblScope><biblScope unit="page" to="27">27</biblScope></imprint><idno type="ISSN">0007-1226</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1226</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arm</term><term>Clinical Trials as Topic</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Hydroxyethylrutoside (administration & dosage)</term><term>Hydroxyethylrutoside (analogs & derivatives)</term><term>Hydroxyethylrutoside (therapeutic use)</term><term>Leg</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (physiopathology)</term><term>Male</term><term>Mastectomy</term><term>Middle Aged</term><term>Postoperative Complications (drug therapy)</term><term>Random Allocation</term><term>Rutin (analogs & derivatives)</term><term>Skin Temperature (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Bras</term><term>Complications postopératoires (traitement médicamenteux)</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Jambe</term><term>Lymphoedème (physiopathologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Mastectomie</term><term>Mâle</term><term>Méthode en double aveugle</term><term>O-(bêta-Hydroxyéthyl)rutosides (administration et posologie)</term><term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term><term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term><term>Rutoside (analogues et dérivés)</term><term>Température cutanée ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Hydroxyethylrutoside</term><term>Rutin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term><term>Rutoside</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Skin Temperature</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications postopératoires</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Arm</term><term>Clinical Trials as Topic</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Leg</term><term>Male</term><term>Mastectomy</term><term>Middle Aged</term><term>Random Allocation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Bras</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Jambe</term><term>Mastectomie</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Température cutanée</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: A randomised, double-blind, cross-over trial was performed on 26 patients with post-mastectomy lymphoedema of the arm, and 14 with lymphoedema of the leg. For 6 months, patients took O-(β-hydroxyethyl)-rutosides (oxerutin; “Paroven®”, “Venoruton®”, Zyma) in doses of 3 g/day, or the placebos; then they took the reverse. Measurements (volume, circumferences, tonometry and skin temperature) were made monthly. The active drug reduced the volumes of the limbs (p<0.05 to 0.01) and their circumferences (p<0.05 to 0.001). It increased the softness of the limbs, as shown by the increases in the tonometry values (p<0.01 to 0.001). There was a lowering of the elevated skin temperatures (p<0.05 to 0.001). Patients reported increased comfort and freedom of movement, a lessening of their bursting pains, heaviness and tension (p<0.05 to 0.01), and an increased mobility of their limbs (p<0.0001). Most patients (70%) preferred the active drug (p<0.0001). An increase in general well-being was reported by 97% of patients when taking the active drug compared with 4% for the placebo (p<0.0001).</div></front></TEI><double idat="0007-1226:1988:Piller N:a:double:blind"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name></author><author><name sortKey="Morgan, R Gwyn" sort="Morgan, R Gwyn" uniqKey="Morgan R" first="R. Gwyn" last="Morgan">R. Gwyn Morgan</name></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F1AB2C3158F33CBC34B96C103F24B762D9D9564C</idno><date when="1988" year="1988">1988</date><idno type="doi">10.1016/0007-1226(88)90139-7</idno><idno type="url">https://api.istex.fr/document/F1AB2C3158F33CBC34B96C103F24B762D9D9564C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007132</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007132</idno><idno type="wicri:Area/Istex/Curation">007132</idno><idno type="wicri:Area/Istex/Checkpoint">005A41</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">005A41</idno><idno type="wicri:doubleKey">0007-1226:1988:Piller N:a:double:blind</idno><idno type="wicri:Area/Main/Merge">00F170</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N. B." last="Piller">N. B. Piller</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Faculty of Health Sciences and Education, Sturt College Advanced Education, Bedford Park</wicri:regionArea><wicri:noRegion>Bedford Park</wicri:noRegion></affiliation></author><author><name sortKey="Morgan, R Gwyn" sort="Morgan, R Gwyn" uniqKey="Morgan R" first="R. Gwyn" last="Morgan">R. Gwyn Morgan</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Surgery, The Flinder's Medical Centre, Bedford Park</wicri:regionArea><wicri:noRegion>Bedford Park</wicri:noRegion></affiliation></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J. R." last="Casley-Smith">J. R. Casley-Smith</name><affiliation></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>The Henry Thomas Laboratory (Microcirculation Research), University of Adelaide, Box 498 GPO, Adelaide, SA 5001</wicri:regionArea><wicri:noRegion>SA 5001</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">British Journal of Plastic Surgery</title><title level="j" type="abbrev">YBJPS</title><idno type="ISSN">0007-1226</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1988">1988</date><biblScope unit="volume">41</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="20">20</biblScope><biblScope unit="page" to="27">27</biblScope></imprint><idno type="ISSN">0007-1226</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1226</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: A randomised, double-blind, cross-over trial was performed on 26 patients with post-mastectomy lymphoedema of the arm, and 14 with lymphoedema of the leg. For 6 months, patients took O-(β-hydroxyethyl)-rutosides (oxerutin; “Paroven®”, “Venoruton®”, Zyma) in doses of 3 g/day, or the placebos; then they took the reverse. Measurements (volume, circumferences, tonometry and skin temperature) were made monthly. The active drug reduced the volumes of the limbs (p<0.05 to 0.01) and their circumferences (p<0.05 to 0.001). It increased the softness of the limbs, as shown by the increases in the tonometry values (p<0.01 to 0.001). There was a lowering of the elevated skin temperatures (p<0.05 to 0.001). Patients reported increased comfort and freedom of movement, a lessening of their bursting pains, heaviness and tension (p<0.05 to 0.01), and an increased mobility of their limbs (p<0.0001). Most patients (70%) preferred the active drug (p<0.0001). An increase in general well-being was reported by 97% of patients when taking the active drug compared with 4% for the placebo (p<0.0001).</div></front></TEI></ISTEX><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N B" last="Piller">N B Piller</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgery, Flinder's Medical Centre, Bedford Park, South Australia.</nlm:affiliation><country>Australie</country><placeName><region type="state">Australie-Méridionale</region></placeName><wicri:cityArea>Department of Surgery, Flinder's Medical Centre, Bedford Park</wicri:cityArea></affiliation></author><author><name sortKey="Morgan, R G" sort="Morgan, R G" uniqKey="Morgan R" first="R G" last="Morgan">R G Morgan</name></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1988">1988</date><idno type="RBID">pubmed:3278764</idno><idno type="pmid">3278764</idno><idno type="wicri:Area/PubMed/Corpus">006262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006262</idno><idno type="wicri:Area/PubMed/Curation">006262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006262</idno><idno type="wicri:Area/PubMed/Checkpoint">006262</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006262</idno><idno type="wicri:Area/Ncbi/Merge">009669</idno><idno type="wicri:Area/Ncbi/Curation">009669</idno><idno type="wicri:Area/Ncbi/Checkpoint">009669</idno><idno type="wicri:doubleKey">0007-1226:1988:Piller N:a:double:blind</idno><idno type="wicri:Area/Main/Merge">00F004</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.</title><author><name sortKey="Piller, N B" sort="Piller, N B" uniqKey="Piller N" first="N B" last="Piller">N B Piller</name><affiliation wicri:level="2"><nlm:affiliation>Department of Surgery, Flinder's Medical Centre, Bedford Park, South Australia.</nlm:affiliation><country>Australie</country><placeName><region type="state">Australie-Méridionale</region></placeName><wicri:cityArea>Department of Surgery, Flinder's Medical Centre, Bedford Park</wicri:cityArea></affiliation></author><author><name sortKey="Morgan, R G" sort="Morgan, R G" uniqKey="Morgan R" first="R G" last="Morgan">R G Morgan</name></author><author><name sortKey="Casley Smith, J R" sort="Casley Smith, J R" uniqKey="Casley Smith J" first="J R" last="Casley-Smith">J R Casley-Smith</name></author></analytic><series><title level="j">British journal of plastic surgery</title><idno type="ISSN">0007-1226</idno><imprint><date when="1988" type="published">1988</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arm</term><term>Clinical Trials as Topic</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Hydroxyethylrutoside (administration & dosage)</term><term>Hydroxyethylrutoside (analogs & derivatives)</term><term>Hydroxyethylrutoside (therapeutic use)</term><term>Leg</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (physiopathology)</term><term>Male</term><term>Mastectomy</term><term>Middle Aged</term><term>Postoperative Complications (drug therapy)</term><term>Random Allocation</term><term>Rutin (analogs & derivatives)</term><term>Skin Temperature (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Bras</term><term>Complications postopératoires (traitement médicamenteux)</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Jambe</term><term>Lymphoedème (physiopathologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Mastectomie</term><term>Mâle</term><term>Méthode en double aveugle</term><term>O-(bêta-Hydroxyéthyl)rutosides (administration et posologie)</term><term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term><term>O-(bêta-Hydroxyéthyl)rutosides (usage thérapeutique)</term><term>Rutoside (analogues et dérivés)</term><term>Température cutanée ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Hydroxyethylrutoside</term><term>Rutin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxyethylrutoside</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term><term>Rutoside</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Skin Temperature</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications postopératoires</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Arm</term><term>Clinical Trials as Topic</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Leg</term><term>Male</term><term>Mastectomy</term><term>Middle Aged</term><term>Random Allocation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Bras</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Jambe</term><term>Mastectomie</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Température cutanée</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A randomised, double-blind, cross-over trial was performed on 26 patients with postmastectomy lymphoedema of the arm, and 14 with lymphoedema of the leg. For 6 months, patients took 0-(beta-hydroxyethyl)-rutosides (oxerutin; "Paroven", "Venoruton", Zyma) in doses of 3 g/day, or the placebos; then they took the reverse. Measurements (volume, circumferences, tonometry and skin temperature) were made monthly. The active drug reduced the volumes of the limbs (p less than 0.05 to 0.01) and their circumferences (p less than 0.05 to 0.001). It increased the softness of the limbs, as shown by the increases in the tonometry values (p less than 0.01 to 0.001). There was a lowering of the elevated skin temperatures (p less than 0.05 to 0.001). Patients reported increased comfort and freedom of movement, a lessening of their bursting pains, heaviness and tension (p less than 0.05 to 0.01), and an increased mobility of their limbs (p less than 0.0001). Most patients (70%) preferred the active drug (p less than 0.0001). An increase in general well-being was reported by 97% of patients when taking the active drug compared with 4% for placebo (p less than 0.0001).</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00E480 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 00E480 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:F1AB2C3158F33CBC34B96C103F24B762D9D9564C
|texte= A double-blind, cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs
}}
| This area was generated with Dilib version V0.6.31. |  |